Qube Research & Technologies LTD Xeris Biopharma Holdings, Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 3,089,771 shares of XERS stock, worth $25.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,089,771
Previous 1,844,583
67.51%
Holding current value
$25.9 Million
Previous $10.1 Million
42.49%
% of portfolio
0.02%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding XERS
# of Institutions
207Shares Held
89.4MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$86.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$82.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$32.1 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$31.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$30.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.14B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...